Sustained local delivery of siRNA from an injectable scaffold.

Nelson CE, Gupta MK, Adolph EJ, Shannon JM, Guelcher SA, Duvall CL
Biomaterials. 2012 33 (4): 1154-61

PMID: 22061489 · PMCID: PMC3232066 · DOI:10.1016/j.biomaterials.2011.10.033

Controlled gene silencing technologies have significant, unrealized potential for use in tissue regeneration applications. The design described herein provides a means to package and protect siRNA within pH-responsive, endosomolytic micellar nanoparticles (si-NPs) that can be incorporated into nontoxic, biodegradable, and injectable polyurethane (PUR) tissue scaffolds. The si-NPs were homogeneously incorporated throughout the porous PUR scaffolds, and they were shown to be released via a diffusion-based mechanism for over three weeks. The siRNA-loaded micelles were larger but retained nanoparticulate morphology of approximately 100 nm diameter following incorporation into and release from the scaffolds. PUR scaffold releasate collected in vitro in PBS at 37 °C for 1-4 days was able to achieve dose-dependent siRNA-mediated silencing with approximately 50% silencing achieved of the model gene GAPDH in NIH3T3 mouse fibroblasts. This promising platform technology provides both a research tool capable of probing the effects of local gene silencing and a potentially high-impact therapeutic approach for sustained, local silencing of deleterious genes within tissue defects.

Copyright © 2011 Elsevier Ltd. All rights reserved.

MeSH Terms (11)

Animals Delayed-Action Preparations Hydrogen-Ion Concentration Injections Mice Nanoparticles NIH 3T3 Cells Polyurethanes RNA, Small Interfering RNA Interference Tissue Scaffolds

Connections (5)

This publication is referenced by other Labnodes entities: